# EDGAR Filing Document

**Accession Number:** 0001769484
**File Stem:** 0001641172-25-022808
**Filing Date:** 2025-8
**Character Count:** 17444
**Document Hash:** daa480a86f0b5771c8790ef3428b6b72
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-022808.hdr.sgml**: 20250808

**ACCESSION NUMBER**: 0001641172-25-022808

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250808

**DATE AS OF CHANGE**: 20250808

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bioceres Crop Solutions Corp.
- **CENTRAL INDEX KEY:** 0001769484
- **STANDARD INDUSTRIAL CLASSIFICATION:** AGRICULTURE CHEMICALS [2870]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-90962
- **FILM NUMBER:** 251199284

**BUSINESS ADDRESS:**
- **STREET 1:** PO BOX 309, UGLAND HOUSE
- **CITY:** GEORGE TOWN, GRAND CAYMAN
- **STATE:** E9
- **ZIP:** KY1-1104
- **BUSINESS PHONE:** 54 341 486 1122

**MAIL ADDRESS:**
- **STREET 1:** OCAMPO 210 BIS, PREDIO CCT
- **CITY:** ROSARIO
- **STATE:** C1
- **ZIP:** 2000
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Jasper Lake Ventures One LLC
- **CENTRAL INDEX KEY:** 0002080636

**ORGANIZATION NAME:**
- **EIN:** 863706305
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**BUSINESS ADDRESS:**
- **STREET 1:** 930 SYLVAN AVENUE
- **STREET 2:** SUITE 115
- **CITY:** ENGLEWOOD CLIFFS
- **STATE:** NJ
- **ZIP:** 07632
- **BUSINESS PHONE:** 7866882201

**MAIL ADDRESS:**
- **STREET 1:** 930 SYLVAN AVENUE
- **STREET 2:** SUITE 115
- **CITY:** ENGLEWOOD CLIFFS
- **STATE:** NJ
- **ZIP:** 07632

## Exhibit 99.1

**EXHIBIT 99.1**

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto as well as the filing of, and reference to, this agreement as an exhibit thereto) with respect to the Ordinary Shares, par value $0.0001 per share, of Bioceres Crop Solutions Corp. This Joint Filing Agreement shall be filed as an Exhibit to such Statement. The undersigned acknowledge that each shall be responsible for the timely filing of any amendments to such joint filing and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others. This agreement shall remain in full force and effect until revoked by any party hereto in a signed writing provided to each other party hereto, and then only with respect to such revoking party.

This Agreement may be executed in any number of counterparts, each of which shall be deemed an original.

EXECUTED as of this 8<sup>th</sup> day of August, 2025.

---

| | |
|:---|:---|
| **JASPER LAKE VENTURES ONE LLC** | **JASPER LAKE VENTURES ONE LLC** |
| By: | /s/ Noah Kolatch |
| Name: | Noah Kolatch |
| Title: | Authorized Signatory |
| **NOAH KOLATCH** | **NOAH KOLATCH** |
| Signed: | /s/ Noah Kolatch |
| Name: | Noah Kolatch |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**Bioceres Crop Solutions Corp.**

*(Name of Issuer)*

**Ordinary Shares, par value $0.0001**

*(Title of Class of Securities)*

**G1117K114**

*(CUSIP Number)*

**Noah Kolatch**<br>930 Sylvan Avenue<br>Suite 140<br>Englewood Cliffs NJ 07632<br>(786) 688-2201

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**08/01/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **G1117K114** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Jasper Lake Ventures One LLC** | Name of reporting person<br>**Jasper Lake Ventures One LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**7382919.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**7382919.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**7382919.00** | Aggregate amount beneficially owned by each reporting person<br>**7382919.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**10.6%** | Percent of class represented by amount in Row (11)<br>**10.6%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Comment for Reporting Person:** The number of shares in rows 8, 10 and 11 consists of 397,000 Ordinary Shares held by Jasper Lake as of the filing of this Schedule 13D plus the Ordinary Shares issuable upon the conversion of the Notes held by Jasper Lake. The percentage set forth in Row 13 is calculated based on (i) 62,712,602 Ordinary Shares of the Issuer outstanding as of March 31, 2025, as reported in the Issuer's current report on Form 6-K filed with the Commission on June 20, 2025, plus (ii) 6,985,919 Ordinary Shares issuable upon the conversion of the Note, which is convertible within 60 days of this Schedule 13D.

| **CUSIP No.** | **G1117K114** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Noah Kolatch** | Name of reporting person<br>**Noah Kolatch** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**7382919.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**7382919.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**7382919.00** | Aggregate amount beneficially owned by each reporting person<br>**7382919.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**10.6%** | Percent of class represented by amount in Row (11)<br>**10.6%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** The number of shares in Rows 8, 10 and 11 consists of 397,000 Ordinary Shares held by Jasper Lake as of the filing of this Schedule 13D plus the Ordinary Shares issuable upon the conversion of the Notes held by Jasper Lake. The percentage set forth in Row 13 is calculated based on (i) 62,712,602 Ordinary Shares of the Issuer outstanding as March 31, 2025, as reported in the Issuer's current report on Form 6-K filed with the Commission on June 20, 2025, plus (ii) 6,985,919 Ordinary Shares issuable upon the conversion of the Notes, which is convertible within 60 days of this Schedule 13D.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Ordinary Shares, par value $0.0001

**(b) Name of Issuer:**
Bioceres Crop Solutions Corp.

**(c) Address of Issuer's Principal Executive Offices:**
Ocampo 210 bis, Predio CCT, Rosario, C1, 2000

Information given in response to each item shall be deemed incorporated by reference in all other items, as applicable.

**Item 4. Purpose of Transaction**

The information in Item 3 of this Schedule 13D is incorporated by reference into this Item 4.

The Reporting Persons acquired the Notes (and the Ordinary Shares into which such Notes may be converted) for investment purposes in Jasper Lake's ordinary course of business. The Reporting Persons have had discussions with members of the Issuer's management and members of the Issuer's Board in connection with the Reporting Persons' investment in the Issuer and Noah Kolatch's membership on the Board and may from time to time have further discussions with directors and officers of the Issuer, or discussions with other shareholders or third parties regarding the Issuer's business operations, strategies, capital structure, assets, liabilities and other matters related to the Issuer. The Reporting Persons, including as a member of the Board, may engage in a number of conversations that may relate to one or more of the items in subsections (a) through (j) of Item 4 of Schedule 13D, including options for maximizing shareholder value, enhancing the Issuer's corporate governance, improving capital, asset or liability allocation, monetizing the Issuer's assets, various strategic alternatives or operational or management initiatives, and the other Reporting Persons may also participate in those conversations as investors. The Reporting Persons may, at any time and from time to time, review or reconsider their position and/or change their purpose and/or formulate plans or proposals with respect thereto.

The Reporting Persons intend to review their investment in the Issuer on a continuing basis and may from time to time and at any time in the future depending on various factors, including, without limitation, the Issuer's financial position and strategic direction, actions taken by the Board, price levels of the Issuer's securities, other investment opportunities available to the Reporting Persons, conditions in the securities market and general economic and industry conditions, take such actions with respect to the investment in the Issuer as they deem appropriate. Subject to the Issuer's insider trading policy, these actions may include: (i) acquiring additional Ordinary Shares and/or other equity, notes, other securities, derivatives or other instruments that are based upon or relate to the value of securities of the Issuer, or any debt of the Issuer or its affiliates, irrespective of whether it is a security (collectively, "Instruments") in the open market or otherwise; (ii) disposing of any or all of their Instruments in the open market or otherwise; (iii) engaging in any hedging or similar transactions with respect to the Instruments; or (iv) proposing or considering one or more of the actions described in subsections (a) through (j) of Item 4 of Schedule 13D.

Except as described in this Schedule 13D, the Reporting Persons do not have any present plans or proposals that relate to or would result in any of the actions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D, although, subject to the agreements described herein, the Reporting Persons, at any time and from time to time, may review, reconsider and change their position and/or change their purpose and/or develop such plans and may seek to influence management or the Board with respect to the business and affairs of the Issuer and may from time to time consider pursuing or proposing such matters with advisors, the Issuer or other persons. Although the foregoing reflects plans and proposals presently contemplated by each Reporting Person with respect to the Issuer, the foregoing is subject to change at any time and is dependent upon contingencies and assumed and speculative conditions, and there can be no assurance that any of the actions set forth above will be taken.

**Item 5. Interest in Securities of the Issuer**

**(a)**
Each Reporting Person may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for the purposes of Section 13(d) or 13(g) of the Act. Each Reporting Person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, (i) acting (or has agreed or is agreeing to act) with any other person as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring holding, or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer or (ii) a member of any syndicate or group with respect to the Issuer or any securities of the Issuer.

Items 7 through 11 and 13 of each of the cover pages of this Schedule 13D are incorporated herein by reference.

The percentages set forth herein are calculated based on (i) 62,712,602 Ordinary Shares of Bioceres Crop Solutions Corp. (the "Issuer") outstanding as March 31, 2025, as reported in the Issuer's current report on Form 6-K filed with the U.S. Securities and Exchange Commission (the "Commission") on June 20, 2025, plus 6,985,919 Ordinary Shares that the Reporting Persons currently have the right to acquire within 60 days upon conversion of the Notes.

**(b)**
As of August 1, 2025, the Reporting Persons held or had a right to receive an aggregate of 7,382,919 Ordinary Shares of the Issuer, which constitutes approximately 10.6% of the outstanding Ordinary Shares of the Issuer.

Number of shares as to which each Reporting Person has:

(i) sole power to vote or to direct the vote:

See Item 7 on the cover pages hereto.

(ii) shared power to vote or to direct the vote:

See Item 8 on the cover pages hereto.

(iii) sole power to dispose or to direct the disposition of:

See Item 9 on the cover pages hereto.

(iv) shared power to dispose or to direct the disposition of:

See Item 10 on the cover pages hereto.

Each of Noah Kolatch, Jonathan Kolatch, and Joseph Kolatch as a principal of Jasper Lake may be deemed to exercise voting and investment power over the Ordinary Shares directly held by Jasper Lake (including Ordinary Shares into which the Note may be converted).

Each of them disclaims beneficial ownership over all securities beneficially owned by Jasper Lake, other than for the purpose of determining obligations under the Exchange Act, and the filing of this Schedule 13D shall not be deemed an admission that any of them is the beneficial owner of such securities for any other purpose.

**(c)**
Except as disclosed in this Schedule 13D, no transactions in the Ordinary Shares or securities convertible into, exercisable for, or exchangeable for Ordinary Shares were effected during the past sixty days by the Reporting Persons.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

The information in Items 3 and 4 of this Schedule 13D is incorporated by reference into this Item 6.

Joint Filing Agreement

Pursuant to Rule 13d-1(k) promulgated under the Exchange Act, the Reporting Persons have entered into a Joint Filing Agreement with respect to the joint filing of this statement and any amendments hereto, a copy of which is filed as Exhibit 99.1 hereto.

Except as otherwise described herein, including the Notes and the Joint Filing Agreement, no Reporting Person has any contract, arrangement, understanding, or relationship with any person with respect to the Ordinary Shares of the Issuer or any other securities of the Issuer.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Jasper Lake Ventures One LLC

**Signature:** /s/ Noah Kolatch

**Name/Title:** Noah Kolatch, Authorized Signatory

**Date:** 08/08/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Noah Kolatch

**Signature:** /s/ Noah Kolatch

**Name/Title:** NOAH KOLATCH

**Date:** 08/08/2025